Washington, DC - Heart failure treated with cardiac resynchronization therapy (CRT) is most likely to improve clinically and least likely to cause hospitalization or death when the biventricular ...

BOSTON -- Early cardiac resynchronization therapy (CRT) benefited patients with moderately reduced ejection fraction (EF) and left bundle branch block (LBBB) but no indication for pacing, according to ...

The survival benefit of a cardiac resynchronization therapy-defibrillator (CRT-D) lasts for several years in patients with mild-to-moderate symptoms of heart failure (HF), a reduced ejection fraction, ...

SILVER SPRING, MD — Women, compared with men, showed improved survival from cardiac resynchronization therapy (CRT) across a wider range of prolonged QRS durations, a key factor in guidelines-based ...

EBR Systems Inc. raised AU$55.9 million (US$36 million) to commercialize its Wise cardiac resynchronization therapy system following U.S. FDA approval in April of the wireless, endocardial pacing ...

CHICAGO (Reuters) - Medtronic Inc said on Tuesday a study of device therapy in patients with mild heart failure missed its primary goal on a measure of disease progression, but some patients saw their ...